Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - glibenklamid; metformin - filmsko obložena tableta - glibenklamid 5 mg / 1 tableta  metformin390 mg / 1 tableta; metformin 390 mg / 1 tableta - metformin in sulfonilsečnine

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin

Euroopan unioni - sloveeni - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Euroopan unioni - sloveeni - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk d.o.o., ljubljana - ceftazidim - prašek za raztopino za injiciranje/infundiranje - ceftazidim 1 g / 1 viala - ceftazidim

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

prašek za peroralno raztopino - metformin

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - pantoprazol - prašek za raztopino za injiciranje - pantoprazol 40 mg / 1 viala - pantoprazol

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - pantoprazol - prašek za raztopino za injiciranje - pantoprazol 40 mg / 1 viala - pantoprazol

Slovenia - sloveeni - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

accord healthcare - pantoprazol - prašek za raztopino za injiciranje - pantoprazol 40 mg / 1 viala - pantoprazol